Color-code system boosts biomarker analysis reach; Prostate cancer hormone enables treatment resistance;

> University of Washington scientists have come up with a new process to color-code cells that lets them illuminate 100 biomarkers for analysis of cells from cultures or tissue biopsies--10 times as many as current standards allow. Item

> Johns Hopkins scientists and others have identified a biomarker--a fat cell hormone--that appears to predict how severe a migraine will become. Release

> A team at Sanford-Burnham Medical Research Institute in California figured out that the Siah2 protein works to enable prostate cancer cells to resist hormone therapy--making it a viable new biomarker and target for treatment. Story

> A $4.1 million grant from the Massachusetts Life Sciences Center will fund the new Forsyth Center for Salivary Diagnostics, which will work with multiple research partners to develop biomarkers in saliva for various conditions such as tuberculosis and strokes. Item

> Researchers at the University of Pennsylvania determined that multimodal imaging is more accurate in spotting biomarkers that signify frontotemporal degeneration, which can cause dementia in patients under age 60 through tau or TDP-43 protein mutations in the brain.  Release

And Finally... Amyloid plaque--an Alzheimer's biomarker--has been linked to poor sleep quality, but not changes in sleep quantity. Item

Suggested Articles

Sherlock Biosciences teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech in oncology, infections and the coronavirus.

The spine surgery company ATEC has moved to acquire Paris-based EOS imaging, makers of FDA-cleared scanners and 3D orthopedic planning software.

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.